Experience the EOSTM Plug in Action

ArtVentive has developed the Endoluminal Occlusion System (EOSTM), a plug, achieving immediate, complete, and permanent occlusion of peripheral vasculature.

About ArtVentive

About ArtVentive

Learn more about the company behind our innovative success

Meet EOS

 Meet the EOSTM Plug

View the vascular plug that redefines peripheral embolization

Case Studies

Case Studies

Explore selected cases, and see how the EOSTM Plug improves clinical outcomes

News and Events

EOS Plug featuring in five abstracts/posters at GEST, Miami Beach, May 17-20

ArtVentive’s EOS Plug will be presented in five abstracts/posters at the GEST 2018 US conference, in Miami Beach, from May 17 – 20. Physicians from Germany, Italy, the Netherlands and the US will present their clinical experience with the EOS Plug. Also, there will be an opportunity for hands-on with the EOS Plug in workshops dedicated to embolization plugs. Please register to make sure you can access the workshop. At the ArtVentive booth we show you the EOS Plug and discuss latest clinical cases and indications. Read More.

ArtVentive at the SIR meeting, Los Angeles, March 17-22, 2018

Visit us at booth #845 to learn more about the EOS™ Plug and its unique ability to immediately occlude blood flow in veins and arteries: www.sirmeeting.org.   On Tuesday, March 20th from 3pm-4:30pm, a hands-on Coils, Plugs & Embolics workshop is scheduled. The ArtVentive EOS™ Plug will be presented and demonstrated. Read More.

News Release: Corporate Update – APRIL 2017

We started commercial sales activity of the ArtVentive EOS™ in April 2016. From the very beginning, ArtVentive adopted a focused approach to the sales process, development and continuous growth. In the European markets, we market and sell our products through industry distributors. In the U.S, we market directly to selected University Hospitals and private clinics constantly expanding of customer base. We have targeted sales and marketing efforts to interventional radiologists and vascular surgeons with experience using similar catheter-based procedures, such as angioplasty and stenting. Peer-to-peer education is also a key element of our sales strategy. Our progress to date has been significant where we have achieved 400 – 500% sales growth per quarter. Management is very confident in the sales development and our company’s expansion based on natural organic growth. Read More.